A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations

Three critical aspects that define high concentration antibody products (HCAPs) are as follows: 1) formulation composition, 2) dosage form, and 3) primary packaging configuration. HCAPs have become successful in the therapeutic sector due to their unique advantage of allowing subcutaneous self-admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Indrajit, Gutka, Hiten, Krause, Mary E., Clemens, Ryan, Kashi, Ramesh S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228404/
https://www.ncbi.nlm.nih.gov/pubmed/37243580
http://dx.doi.org/10.1080/19420862.2023.2205540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228404/
https://www.ncbi.nlm.nih.gov/pubmed/37243580
http://dx.doi.org/10.1080/19420862.2023.2205540

Ejemplares similares